These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 23788817)

  • 21. Modifying a traditional course for the PharmD curriculum.
    Ference JD; Medina MS
    Am J Pharm Educ; 2008 Oct; 72(5):122. PubMed ID: 19214277
    [No Abstract]   [Full Text] [Related]  

  • 22. A distance-learning programme in pharmacovigilance linked to educational credits is associated with improved reporting of suspected adverse drug reactions via the UK yellow card scheme.
    Bracchi RC; Houghton J; Woods FJ; Thomas S; Smail SA; Routledge PA
    Br J Clin Pharmacol; 2005 Aug; 60(2):221-3. PubMed ID: 16042677
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Implementing a centralised pharmacovigilance service in a non-commercial setting in the United Kingdom.
    Dinnett EM; Kean S; Tolmie EP; Ronald ES; Gaw A
    Trials; 2013 Jun; 14():171. PubMed ID: 23758677
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adverse drug reaction teaching in UK undergraduate medical and pharmacy programmes.
    Cox AR; Marriott JF; Wilson KA; Ferner RE
    J Clin Pharm Ther; 2004 Feb; 29(1):31-5. PubMed ID: 14748895
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Undergraduate and postgraduate pharmacovigilance education: A proposal for appropriate curriculum content.
    Herrera Comoglio R
    Br J Clin Pharmacol; 2020 Apr; 86(4):779-790. PubMed ID: 31770452
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Electronic Reporting Systems in Pharmacovigilance: The Implementation of VigiFlow in Brazil.
    Vogler M; Ricci Conesa H; de Araújo Ferreira K; Moreira Cruz F; Simioni Gasparotto F; Fleck K; Maciel Rebelo F; Kollross B; Silveira Gonçalves Y
    Pharmaceut Med; 2020 Oct; 34(5):327-334. PubMed ID: 32930977
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The development and piloting of "ATTEND DR," a clinical teaching tool to identify and prioritize potential causes of adverse drug reactions.
    King M; Khan S
    Curr Pharm Teach Learn; 2017; 9(1):66-71. PubMed ID: 29180157
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Invitation to Faculty of Pharmaceutical Sciences, Nagasaki International University].
    Nodake Y; Fukasawa M; Sakakibara R
    Seikagaku; 2008 May; 80(5):444-6. PubMed ID: 18575233
    [No Abstract]   [Full Text] [Related]  

  • 29. A renaissance in pharmacy education at the University of North Carolina at Chapel Hill.
    Roth MT; Mumper RJ; Singleton SF; Lee CR; Rodgers PT; Cox WC; McLaughlin JE; Joyner P; Blouin RA
    N C Med J; 2014; 75(1):48-52. PubMed ID: 24487762
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reporting adverse drug reactions: contribution, knowledge and perception of German pharmacy professionals.
    Laven A; Schmitz K; Franzen WH
    Int J Clin Pharm; 2018 Aug; 40(4):842-851. PubMed ID: 29909562
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Useful resources for members serving on a curriculum committee in schools and colleges of pharmacy.
    Dorval E; Thornby KA; Ottman A; Hubbard M
    Curr Pharm Teach Learn; 2017; 9(1):145-154. PubMed ID: 29180147
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical pharmacy undergraduate education in China: a comparative analysis based on ten universities' training programs.
    Li J; Xiao C; Hou J; Zhao Y; Gong H; Zhang B; Yan M
    BMC Med Educ; 2023 Feb; 23(1):83. PubMed ID: 36732755
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The ISoP CommSIG for Improving Medicinal Product Risk Communication: A New Special Interest Group of the International Society of Pharmacovigilance.
    Bahri P; Dodoo AN; Edwards BD; Edwards IR; Fermont I; Hagemann U; Hartigan-Go K; Hugman B; Mol PG
    Drug Saf; 2015 Jul; 38(7):621-7. PubMed ID: 26032946
    [No Abstract]   [Full Text] [Related]  

  • 34. Patient Reporting of Adverse Drug Reactions (ADRs): Survey of Public Awareness and Predictors of Confidence to Report.
    Hariraj V; Aziz Z
    Ther Innov Regul Sci; 2018 Nov; 52(6):757-763. PubMed ID: 29714567
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Postgraduate Education in Pharmaceutical Medicine in Australia: Evaluation and Evolution to a Global Program Over 20 Years.
    Allen GM; Chisholm O
    Ther Innov Regul Sci; 2019 Sep; 53(5):654-660. PubMed ID: 30286618
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adverse drug reaction and medication error reporting by pharmacy students.
    Sears EL; Generali JA
    Ann Pharmacother; 2005 Mar; 39(3):452-9. PubMed ID: 15701765
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Active student engagement in curriculum development.
    Lu CY; Nguyen Q; Ersin OH
    Am J Pharm Educ; 2015 Mar; 79(2):30. PubMed ID: 25861111
    [No Abstract]   [Full Text] [Related]  

  • 38. What is missing in the Bachelor of Science clinical pharmacy program in China?
    Yang CQ; Madiha
    Am J Pharm Educ; 2014 Apr; 78(3):65. PubMed ID: 24761026
    [No Abstract]   [Full Text] [Related]  

  • 39. Redesign of a required undergraduate pharmacy management course to improve student engagement and concept retention.
    Perepelkin J
    Am J Pharm Educ; 2012 Dec; 76(10):201. PubMed ID: 23275666
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Knowledge, attitudes and practices of pharmacists about pharmacovigilance, Libya.
    Atia A; Botto A; Alarbi S
    East Mediterr Health J; 2021 Jul; 27(7):693-697. PubMed ID: 34369584
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.